Thermal Ablation for Colorectal Liver Metastases: Current Evidence and Future Horizons.

Xinliang Liu, Wenlong Qiu, Zhiguang Hu, Qian Liu

Abstract readReview

In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinliang LiuDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Wenlong QiuDepartment of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Zhiguang HuDepartment of Ultrasound, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Qian LiuDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Funding

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences 2022-I2M-C&T-B-057National High Level Hospital Clinical Research Funding, Cooperation Fund of Cancer Hospital of Chinese Academy of Medical Sciences CFA202502001

6 · The paper itself

Abstract

Liver metastasis constitutes the principal cause of mortality in colorectal cancer, with about 50% of patients developing liver metastasis during disease progression. While surgical resection remains the cornerstone of curative-intent treatment, thermal ablation is rapidly reshaping the landscape of local tumor control in well-selected individuals. This comprehensive review analyzes the evolving role of thermal ablation in the management of resectable, unresectable, and recurrent disease, with the aim of establishing contemporary best practices and identifying critical frontiers for future research.

Indexed as

colorectal cancerliver metastasismicrowave ablationradiofrequency ablationthermal ablation

Identifiers

PMID42510100

DOI10.3390/diagnostics16142239

PMCPMC13408316

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.